openPR Logo

Press Releases from Diapharm (12 total)

Diapharm assists in EU registration of Chinese medicines

Diapharm ( has opened its representative office in Shanghai in July 2014 in reaction to a surging demand for pharmaceutical consultancy services in China. Diapharm helps pharmaceutical companies to obtain drug approval in Europe and assists them in quality assurance. “We will advise and assist Chinese companies as they make their way to Europe and also support European companies that purchase active ingredients or finished products from China and that

Diapharm implements European GMP guidelines in China

Münster (DE), London (UK), Ningbo (CN), 20 December 2013 – Pharmaceutical service provider Diapharm ( is increasing its business activities in China: Diapharm has now implemented a “European” quality management system for Neptune Pharma Ltd ( in their Joint Venture Partner’s factory in Ningbo, Zhejiang Province. And it has done so successfully: The veterinary medicinal product Trident 500mg/g Powder for Suspension for Fish Treatment (, is manufactured onsite under EU

Egyptian Ministry of Health invites Diapharm to exchange knowledge

Cairo (EG), Muenster (DE), 11 October, 2012. At a 3-day workshop in Cairo, pharmaceutical service provider Diapharm ( presented the European regulations on medication demarcation areas to representatives of the Egyptian Ministry of Health. Currently, Egypt is revising its legislation regarding medical products, nutritional supplements and self-medication products and is considering, at least partially, taking into account EU legislation. The objective is to improve the availability of safer products. “Diapharm provided

A first for Portugal: Diapharm obtains registration for a traditional medicinal …

Lisbon (PT), Münster, Oldenburg (DE), 25. June 2012 – Pharmaceutical service provider Diapharm ( has now also paved the way for traditional herbal medicinal products in Portugal. The Portuguese National Authority for Medicines and Health Products (INFARMED) has granted a second registration for a traditional medicinal product. “Historically, this type of registration is unusual for Portugal, and it is a sign that traditional herbal medicinal products for self-medication are gaining

Granulox wound spray granted CE mark thanks to Diapharm

Georgsmarienhütte, Lübeck (Germany) 24 April 2012. With its wound spray Granulox, SastoMed GmbH has recently brought a new medical device to market. It improves oxygen supply to chronic wounds, using haemoglobin as the transporter. SastoMed has engaged Diapharm ( to perform the certification of the Class III medical device, and the outcome has been a great success: only 16 months elapsed between Day 1 and the granting of an EU-wide

Diapharm to raise international awareness of country-specific traditional medici …

London (UK), Münster (DE), 14 November 2011 – Pharmaceutical service provider Diapharm ( is planning to raise the profile of traditional herbal medicinal products which have to date only been used in individual EU countries. For this reason, Diapharm has now applied in several European countries for registration of a product for migraine prophylaxis containing the active ingredient feverfew (lat.: tanacetum parthenium). “In the United Kingdom, feverfew has been used

Diapharm adds Anja Kapelski to its GMP and Quality Management consultancy team i …

Bielefeld (DE), Münster (DE), 12 July 2011. Diapharm is expanding its GMP and Quality Management consultancy team. From July, Anja Kapelski has joined the team at the Bielefeld office. Her role at the pharmaceutical service provider will be to plan and implement the development of GMP compliant management systems for pharmaceutical companies. Diapharm advises manufacturers of medicinal products and medical devices on quality issues and can, for example, be present

Dr. Thomas Baierl is the new team leader of Regulatory Affairs at Diapharm

Münster (Germany), 20 April 2010. By hiring Dr. Thomas Baierl, Diapharm ( has added to its staff at the Münster location as of 1 April 2010. At the same time, the pharmaceutical industry service provider is improving its ability to provide consultancy services for prescription medicinal products. Baierl, who has a doctorate in biology, is taking over management of the Regulatory Affairs Pharma team at Diapharm. Together with his team

Diapharm consolidates leading position in traditional-use herbal registrations

Marlow (UK), Oldenburg (DE), 18 March 2009. The decision by the British regulatory agency MHRA on “RelaxHerb” in early March 2009 was double cause for celebration, in Marlow in the UK and in Oldenburg, Germany: firstly by registration holder Schwabe Pharma (UK) Ltd. which, with the traditional herbal medicinal product, now has in its portfolio a product for alleviating symptoms associated with stress. And secondly by regulatory service provider Diapharm

Diapharm starts GMP audit service for active pharmaceutical ingredients

Münster (Germany), 11 September 2008. Pharma service provider Diapharm ( is now offering accredited shared third-party audits for active pharmaceutical ingredients (APIs). In a shared audit several medicinal product manufacturers jointly commission the check of production conditions for a starting material or API such as ibuprofen or naproxen. The resulting audit report serves to prove whether the rules of good manufacturing practice (GMP) are followed in the manufacture of the

Dr. Franz-Josef Kappenberg is new qualified person at HÄLSA Pharma

Münster (Germany), 10 September 2008. On 1 September, Dr. Franz-Josef Kappenberg joined the team at Münster, Germany, pharma service provider HÄLSA Pharma GmbH. The registered pharmacist is its new qualified person, specializing in consultancy on good manufacturing practice (GMP). HÄLSA, a Diapharm company (, advises manufacturers of medicinal products on matters such as setting up quality assurance systems or the preparatory and follow-up work for GMP inspections by the authorities.

DIA Annual Meeting - Call for stronger product claims for traditional herbal med …

Boston (USA), Oldenburg (Germany), 4. July 2008. “Claims granted for a medicinal product, even a traditional one, must be clearly differentiated against claims for food supplements and must be more valuable.” This was the view put forward by Dr. Rainer Kolkmann of the pharmaceutical service provider Diapharm ( on Wednesday 25 June at the Annual Meeting of the Drug Information Association in Boston, USA. Only if the authorities approve robust

Go To Page:   1 2 3 4 5 6 7 8 9 10